{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:15:52Z","timestamp":1789596952133,"version":"build-2803163510"},"update-to":[{"DOI":"10.1002\/14651858.cd012214","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T00:00:00Z","timestamp":1509062400000}}],"reference-count":54,"publisher":"Wiley","issue":"10","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012214.pub2","type":"journal-article","created":{"date-parts":[[2017,10,27]],"date-time":"2017-10-27T13:21:09Z","timestamp":1509110469000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Metformin for endometrial hyperplasia"],"prefix":"10.1002","volume":"2017","author":[{"given":"Naomi S","family":"Clement","sequence":"first","affiliation":[{"name":"University of Nottingham; Faculty of Health Sciences and Medicine; Queen's Medical Centre, Derby Road Nottingham UK NG7 2UH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas RW","family":"Oliver","sequence":"additional","affiliation":[{"name":"Addenbrooke's Hospital, Cambridge University Hospitals NHS Foundation Trust; Department of Histopathology; Hills Road Cambridge Cambridgeshire UK CB2 0QQ"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hunain","family":"Shiwani","sequence":"additional","affiliation":[{"name":"Leeds Teaching Hospitals NHS Trust; Department of Radiology; Great George Street Leeds UK LS1 3EX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliane RF","family":"Sanner","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Faculty of Health Sciences and Medicine; Queen's Medical Centre Derby Road Nottingham Nottinhgamshire UK NG7 2UH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline A","family":"Mulvaney","sequence":"additional","affiliation":[{"name":"University of Nottingham; School of Medicine; Nottingham UK NG7 2UH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Atiomo","sequence":"additional","affiliation":[{"name":"The University of Nottingham; Faculty of Health Sciences and Medicine; Queen's Medical Centre Derby Road Nottingham Nottinhgamshire UK NG7 2UH"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2017,10,27]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD012214.pub2-BIB0001|cit1","doi-asserted-by":"publisher","first-page":"164","DOI":"10.3802\/jgo.2014.25.3.164","article-title":"Conservative treatment for atypical endometrial hyperplasia: what is the most effective therapeutic method?","volume":"25","author":"Kim","year":"2014","journal-title":"Journal of Gynacologic Oncology"},{"issue":"3","key":"10.1002\/14651858.CD012214.pub2-BIB0002|cit2","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3802\/jgo.2014.25.3.214.","article-title":"Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia","volume":"25","author":"Shan","year":"2014","journal-title":"Journal of Gynecologic Oncology"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0003|cit3","doi-asserted-by":"crossref","unstructured":"Shan W Wang C Zhang Z Gu C Ning C Luo X Conservative therapy with metformin plus megestrol acetate for endometrial atypical hyperplasia: preliminary results of a pilot study International Journal of Gynecological Cancer Philadelphia Lippincott Williams & Wilkins 2014 1306 7","DOI":"10.3802\/jgo.2014.25.3.214"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0004|cit4","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1080\/09513590.2016.1223285","article-title":"A comparison between the effects of metformin and megestrol on simple endometrial hyperplasia","author":"Sharifzadeh","year":"2016","journal-title":"Gynecological Endocrinology"},{"issue":"23","key":"10.1002\/14651858.CD012214.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"10067","DOI":"10.7314\/APJCP.2014.15.23.10067","article-title":"Antiproliferative effect of metformin on the endometrium - a clinical trial","volume":"15","author":"Tabrizi","year":"2014","journal-title":"Asian Pacific Journal of Cancer Prevention"},{"issue":"2","key":"10.1002\/14651858.CD012214.pub2-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3109\/09513590.2012.706671","article-title":"Life-style and metformin for the prevention of endometrial pathology in postmenopausal women","volume":"29","author":"Campagnoli","year":"2013","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0007|cit7","unstructured":"IRCT201412085563N6 Vice Chancellor for Research Tabriz University of Medical Sciences The effect of letrozole and metformin on endometrial histology in patients with disordered proliferative endometrium and simple hyperplasia uterus cancer www.irct.ir 2015"},{"issue":"4","key":"10.1002\/14651858.CD012214.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"402.e1","DOI":"10.1016\/j.ajog.2006.12.025","article-title":"The effects of metformin and rosiglitazone, alone and in combination, on the ovary and endometrium in polycystic ovary syndrome","volume":"196","author":"Legro","year":"2007","journal-title":"American Journal of Obstetrics and Gynecology"},{"issue":"19","key":"10.1002\/14651858.CD012214.pub2-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1002\/cncr.28853","article-title":"Effects of metformin on endometrial cancer cell growth in vivo: a preoperative prospective trial","volume":"120","author":"Mitsuhashi","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1002\/14651858.CD012214.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/annonc\/mdv539","article-title":"Phase II study of medroxyprogesterone acetate plus metformin as a fertility-sparing treatment for atypical endometrial hyperplasia and endometrial cancer","volume":"27","author":"Mitsuhashi","year":"2016","journal-title":"Annals of Oncology"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0011|cit11","unstructured":"NCT01685762. UNC Lineberger Comprehensive Cancer Center Metformin for the Treatment of Endometrial Hyperplasia clinicaltrials.gov 2017"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0012|cit12","unstructured":"NCT02035787. UNC Lineberger Comprehensive Cancer Center Metformin With the Levonorgestrel-Releasing Intrauterine Device for the Treatment of Complex Atypical Hyperplasia (CAH) and Endometrial Cancer (EC) in Non-surgical Patients clinicaltrials.gov 2014"},{"issue":"2","key":"10.1002\/14651858.CD012214.pub2-BIB0013|cit13","first-page":"207","article-title":"Metformin treatment and evolution of endometrial cancer","volume":"17","author":"Perez-Lopez","year":"2014","journal-title":"Climacteric"},{"issue":"2","key":"10.1002\/14651858.CD012214.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ygyno.2014.07.086","article-title":"The American Society of Clinical Oncology 50th Annual Meeting 2014: an overview and summary of selected abstracts","volume":"134","author":"Randall","year":"2014","journal-title":"Gynecologic Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012214.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/AOG.0b013e3181719b92","article-title":"Reverse of progestin-resistant atypical endometrial hyperplasia by metformin and oral contraceptives","volume":"112","author":"Shen","year":"2008","journal-title":"Obstetrics & Gynecology"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0016|cit16","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/S0140-6736(15)60405-6","article-title":"A presurgical window-of-opportunity study of metformin in obesity-driven endometrial cancer","volume":"385 North Ameri","author":"Sivalingam","year":"2015","journal-title":"The Lancet"},{"issue":"3","key":"10.1002\/14651858.CD012214.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/bjc.2015.453","article-title":"Measuring the biological effect of presurgical metformin treatment in endometrial cancer","volume":"114","author":"Sivalingam","year":"2016","journal-title":"British Journal of Cancer"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0018|cit18","doi-asserted-by":"crossref","unstructured":"Sivalingama VN McVeyb R Kitsona S Gilmourc K Alid S Robertsa C Pre-surgical window study of metformin in obesity-driven endometrial cancer Gynecologic Oncology 2015 18 0.1016\/j.ygyno.2015.01.042","DOI":"10.1016\/j.ygyno.2015.01.042"},{"issue":"3","key":"10.1002\/14651858.CD012214.pub2-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.ygyno.2015.09.078","article-title":"Prognostic factors of oncological and reproductive outcomes in fertility-sparing treatment of complex atypical hyperplasia and low-grade endometrial cancer using oral progestin in Chinese patients","volume":"139","author":"Zhou","year":"2015","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0020|cit20","unstructured":"IRCT201410275283N11 Comparison of metformin-megestrol combination and megestrol alone on endometrial histology in patients with disordered proliferative or hyperplastic endometrium. http:\/\/en.search.irct.ir\/view\/20539"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0021|cit21","unstructured":"NCT01686126 Improving the treatment for women with early stage cancer of the uterus (feMMe) https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01686126"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0022|cit22","unstructured":"NCT01968317 Megestrol acetate plus metformin to megestrol acetate in patients with endometrial atypical hyperplasia or early stage endometrial adenocarcinoma https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01968317"},{"issue":"6","key":"10.1002\/14651858.CD012214.pub2-BIB0023|cit23","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4161\/cc.8.6.7933","article-title":"Metformin inhibits breast cancer cell growth, colony formation and induces cell cycle arrest in vitro","volume":"8","author":"Alimova","year":"2009","journal-title":"Cell Cycle (Georgetown, Tex)"},{"issue":"13","key":"10.1002\/14651858.CD012214.pub2-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1158\/0008-5472.CAN-10-1769","article-title":"Metformin, independent of AMPK, induces mTOR inhibition and cell-cycle arrest through REDD1","volume":"71","author":"Ben Sahra","year":"2011","journal-title":"Cancer Research"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0025|cit25","volume-title":"British National Formulary","author":"Joint Formulary Committee","year":"2017"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0026|cit26","article-title":"Polcystic ovarian syndrome","volume-title":"Polycystic Ovarian Syndrome","author":"Chang","year":"2002"},{"issue":"23","key":"10.1002\/14651858.CD012214.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1200\/JCO.2011.39.7505","article-title":"Diabetes, metformin, and breast cancer in postmenopausal women","volume":"30","author":"Chlebowski","year":"2012","journal-title":"Journal of Clinical Oncology"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0028|cit28","volume-title":"Statistical Power Analysis for the Behavioural Sciences","author":"Cohen","year":"1988"},{"issue":"1","key":"10.1002\/14651858.CD012214.pub2-BIB0029|cit29","first-page":"CD005552","article-title":"Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome","volume":"1","author":"Costello","year":"2007","journal-title":"The Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0030|cit30","unstructured":"Veritas Health Innovation Covidence"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"c2181","DOI":"10.1136\/bmj.c2181","article-title":"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial","volume":"340","author":"Jager","year":"2010","journal-title":"BMJ (Clinical Research ed)"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1741-7015-9-33","article-title":"Understanding the benefit of metformin use in cancer treatment","volume":"9","author":"Dowling","year":"2011","journal-title":"BMC Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012214.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.ejogrb.2009.04.034","article-title":"Effects of metformin on mammalian target of rapamycin in a mouse model of endometrial hyperplasia","volume":"145","author":"Erdemoglu","year":"2009","journal-title":"European Journal of Obstetrics & Gynecology and Reproductive Biology"},{"issue":"1","key":"10.1002\/14651858.CD012214.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.fertnstert.2003.10.004","article-title":"Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome","volume":"81","author":"Rotterdam ESHRE\/ASRM-Sponsored PCOS Consensus Workshop Group","year":"2004","journal-title":"Fertility and Sterility"},{"issue":"5","key":"10.1002\/14651858.CD012214.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/humrep\/det049","article-title":"Relapse of endometrial hyperplasia after conservative treatment: a cohort study with long-term follow-up","volume":"28","author":"Gallos","year":"2013","journal-title":"Human Reproduction (Oxford, England)"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0036|cit36","unstructured":"McMaster University (developed by Evidence Prime) GRADEproGDT 2015"},{"issue":"5","key":"10.1002\/14651858.CD012214.pub2-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1093\/humrep\/des042","article-title":"Evaluating the association between endometrial cancer and polycystic ovary syndrome","volume":"27","author":"Haoula","year":"2012","journal-title":"Human Reproduction (Oxford, England)"},{"issue":"557","key":"10.1002\/14651858.CD012214.pub2-BIB0038|cit38","first-page":"60","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0039|cit39","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011)","author":"Higgins","year":"2011. Available from handbook.cochrane.org"},{"issue":"10","key":"10.1002\/14651858.CD012214.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1111\/j.1600-0412.2012.01458.x","article-title":"The prevalence of endometrial hyperplasia and endometrial cancer in women with polycystic ovary syndrome or hyperandrogenism","volume":"91","author":"Holm","year":"2012","journal-title":"Acta Obstetricia et Gynecologica Scandinavica"},{"issue":"2","key":"10.1002\/14651858.CD012214.pub2-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1002\/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X","article-title":"The behavior of endometrial hyperplasia. A long-term study of \"untreated\" hyperplasia in 170 patients","volume":"56","author":"Kurman","year":"1985","journal-title":"Cancer"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0042|cit42","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1200\/JCO.2009.24.1315","article-title":"Absolute risk of endometrial carcinoma during 20-year follow-up among women with endometrial hyperplasia","volume":"28","author":"Lacey","year":"2010","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"10.1002\/14651858.CD012214.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012214.pub2-BIB0044|cit44","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ygyno.2013.10.026","article-title":"Metformin use and endometrial cancer survival","volume":"132","author":"Nevadunsky","year":"2014","journal-title":"Gynecologic Oncology"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0045|cit45","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"4","key":"10.1002\/14651858.CD012214.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/annonc\/mdq464","article-title":"Metabolic syndrome and endometrial cancer risk","volume":"22","author":"Rosato","year":"2011","journal-title":"Annals of Oncology"},{"issue":"2","key":"10.1002\/14651858.CD012214.pub2-BIB0047|cit47","first-page":"103","article-title":"Evaluation of endometrial histologic morphology in patients with polycystic ovary syndrome","volume":"80","author":"Rudnicka","year":"2009","journal-title":"Ginekologia Polska"},{"issue":"5","key":"10.1002\/14651858.CD012214.pub2-BIB0048|cit48","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1080\/09513590312331290298","article-title":"Treatment of atypical endometrial hyperplasia with an insulin-sensitizing agent","volume":"17","author":"Session","year":"2003","journal-title":"Gynecological Endocrinology"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0049|cit49","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.ygyno.2013.10.028","article-title":"Preventing endometrial caner risk in polycystic ovarian syndrome (PCOS) women: could metformin help?","volume":"132","author":"Shafiee","year":"2014","journal-title":"Gynecologic Oncology"},{"issue":"5","key":"10.1002\/14651858.CD012214.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/AOG.0b013e31826b9fef","article-title":"Risk factors for developing endometrial cancer after benign endometrial sampling","volume":"120","author":"Torres","year":"2012","journal-title":"Obstetrics and Gynecology"},{"issue":"2","key":"10.1002\/14651858.CD012214.pub2-BIB0051|cit51","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s00404-015-3858-z","article-title":"Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives","volume":"293","author":"Vrachnis","year":"2016","journal-title":"Archives of Gynaecology and Obstetrics"},{"issue":"4","key":"10.1002\/14651858.CD012214.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.tem.2011.01.005","article-title":"Progesterone: the ultimate endometrial tumor suppressor","volume":"22","author":"Yang","year":"2011","journal-title":"Trends in Endocrinology and Metabolism"},{"key":"10.1002\/14651858.CD012214.pub2-BIB0053|cit53","first-page":"125","article-title":"Tumours of the Uterine Corpus: Epithelial Tumours and Precursors","volume-title":"WHO Classification of Tumours of Female Reproductive Organs","volume":"6","author":"Zaino","year":"2014"},{"issue":"5","key":"10.1002\/14651858.CD012214.pub2-BIB0054|cit54","doi-asserted-by":"publisher","DOI":"10.1002\/14651858","article-title":"Metformin for endometrial hyperplasia","author":"Clement","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"updated-by":[{"DOI":"10.1002\/14651858.cd012214.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T00:00:00Z","timestamp":1714608000000}}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012214.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T09:23:53Z","timestamp":1679390633000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012214.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Gynaecology and Fertility Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,10,27]]},"references-count":54,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2017,10]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012214.pub2","relation":{"new_version":[{"id-type":"doi","id":"10.1002\/14651858.CD012214.pub3","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,10,27]]}}}